Ureteral stent drug delivery device, kit, and method
AssigneeTARIS Biomedical LLC
InventorsBurleigh M. Hutchins, III, Cheryl Larrivee-Elkins, Heejin Lee, Jim Boyko
Life of this patent
Estimating the term…
Abstract
Ureteral stent devices having improved drug delivery capabilities are provided. The ureteral stent device includes a ureteral stent comprising two opposed ends, and a drug delivery component associated with at least one end of the ureteral stent. The drug delivery component includes a drug housing defining a drug reservoir containing a drug, wherein the drug housing is configured to release the drug in-vivo.
Claims27
An implantable medical device, comprising:
- a ureteral stent comprising two opposed ends;
- and
- a drug delivery component associated with at least one end of the ureteral stent, the drug delivery component comprising a drug housing defining a drug reservoir containing a drug in solid or semi-solid form, wherein the drug housing is configured to release the drug in vivo.
A method of delivering a drug from a ureteral stent device, comprising:
- implanting a ureteral stent device in a ureter of a patient, the ureteral stent device including a drug delivery component comprising a drug housing defining a drug reservoir containing a drug in solid or semi-solid form;
- and
- releasing the drug from the drug delivery component into the patient's body.
A method of treating one or more side effects associated with placement of the ureteral stent in the body, comprising:
- implanting a ureteral stent device in a ureter of a patient, the ureteral stem device including a drug delivery component comprising a drug housing defining a drug reservoir containing a drug in solid or semi-solid form;
- and
- releasing the drug from the ureteral stoat device into the patient, the drug being selected from the group consisting of:
- a local anesthetic agent, an anti-muscarinic, an alpha-blocker, a narcotic, phenazopyridine and combinations thereof.
A medical procedure kit comprising:
- a ureteral stent having a bladder end and a kidney end;
- and
- at least one drug delivery portion with means for attachment to one of the ends of the ureteral stent in-vivo, the drug delivery portion comprising a drug housing defining a drug reservoir containing a drug in solid or semi-solid form.
Dependencies are inferred from the claim text.